Dr. Sid O’Bryant is Dr. Joe and Peggy Schooler Endowed Chair, and Executive Director of the Institute for Translational Research at University of North Texas Health Science Center.
As the population of those aged 65 and over continues to grow, so does the diversity of the U.S. population. In fact, by 2060 approximately 27.5% of the population will be Hispanic and 15%. Dr. Sid O’Bryant is the principal investigator of the Health & Aging Brain Study – Health Disparities (HABS-HD), which is the most comprehensive study of Alzheimer’s disease among the three largest racial/ethnic groups in the U.S. ever conducted – African Americans, Mexican Americans, non-Hispanic whites. The goal of the HABS-HD program is to understand the life course factors, including biological, sociocultural, environmental, and behavioral, that impact risk for Alzheimer’s disease in late life. This work will ultimately lead to population-specific precision medicine approaches to treating and preventing Alzheimer’s disease (i.e., “treating your Alzheimer’s disease”). In addition to being a global leader in Mexican American cognitive aging, Dr. O’Bryant is a global expert in precision medicine approaches to novel diagnostic and therapeutic strategies for Alzheimer’s disease, Parkinson’s disease, Dementia with Lewy Bodies and Alzheimer’s disease among adults with Down Syndrome.
University of North Texas Health Science Center Institute for Translational Research